Identification of an antimalarial synthetic trioxolane drug development candidate
暂无分享,去创建一个
Christian Scheurer | Jonathan L. Vennerstrom | Susan A. Charman | Sergio Wittlin | Daniel Hunziker | Yuanqing Tang | J. Chollet | S. Charman | W. Charman | R. Brun | H. Matile | Reto Brun | Sarah Arbe-Barnes | Jacques Chollet | Yuxiang Dong | Hugues Matile | Heinrich Urwyler | Yuxiang Dong | William N. Charman | J. Vennerstrom | S. Wittlin | A. Dorn | Arnulf Dorn | Francis C. K. Chiu | Kylie McIntosh | Maniyan Padmanilayam | Josefina Santo Tomas | Bernard Scorneaux | D. Hunziker | F. Chiu | H. Urwyler | C. Scheurer | B. Scorneaux | Yuanqing Tang | M. Padmanilayam | J. Tomas | K. McIntosh | S. Arbe-Barnes
[1] Y. Liu,et al. Opening rate of acetylcholine receptor channels. , 1991, Biophysical journal.
[2] H. van de Waterbeemd,et al. Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.
[3] B. Avery,et al. Carrier-Mediated Partitioning of Artemisinin into Plasmodium falciparum-Infected Erythrocytes , 2002, Antimicrobial Agents and Chemotherapy.
[4] R. Gunn,et al. Functional differences among nonerythroid anion exchangers expressed in a transfected human cell line. , 1991, The Journal of biological chemistry.
[5] Qigui Li,et al. The Pharmacokinetics and Bioavailability of Dihydroartemisinin, Arteether, Artemether, Artesunic Acid and Artelinic Acid in Rats , 1998, The Journal of pharmacy and pharmacology.
[6] Solomon Nwaka,et al. Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.
[7] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[8] M. Abe,et al. 18O-Tracer Studies of Fe(II)-Induced Decomposition of 1,2,4-Trioxolanes (Ozonides) Derived from Cyclopentenes and Indenes. Inner-Sphere Electron Transfer Reduction of the Peroxide Linkage , 1999 .
[9] A. Auerbach,et al. The Extracellular Linker of Muscle Acetylcholine Receptor Channels Is a Gating Control Element , 2000, The Journal of general physiology.
[10] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[11] S. Krishna,et al. Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.
[12] E. Kirkness,et al. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors , 2003, Nature.
[13] B. Meunier,et al. Alkylation of heme by the antimalarial drug artemisinin. , 2002, Chemical communications.
[14] F. Sigworth,et al. Data transformations for improved display and fitting of single-channel dwell time histograms. , 1987, Biophysical journal.
[15] K. Ohno,et al. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating , 1999, Nature Neuroscience.
[16] D. L. Klayman,et al. Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .
[17] N. White,et al. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo , 1997, Antimicrobial agents and chemotherapy.
[18] D A Smith,et al. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.
[19] S. Sine. The nicotinic receptor ligand binding domain. , 2002, Journal of neurobiology.
[20] B. W. Penman,et al. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. , 1997, Analytical biochemistry.
[21] S. Sine,et al. Molecular Dissection of Subunit Interfaces in the Acetylcholine Receptor , 1996, The Journal of Biological Chemistry.
[22] Robert G. Ridley,et al. Medical need, scientific opportunity and the drive for antimalarial drugs , 2002, Nature.
[23] F. Theil,et al. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737 , 1997, Antimicrobial agents and chemotherapy.
[24] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[25] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[26] G. Nolan,et al. Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Warhurst,et al. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. , 1987, The Journal of tropical medicine and hygiene.
[28] K. Griesbaum,et al. Ozonolyses of O‐Alkylated Ketoximes in the Presence of Carbonyl Groups: A Facile Access to Ozonides , 1997 .
[29] B. Sakmann,et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.
[30] T. Gordi,et al. Artemisinin derivatives: toxic for laboratory animals, safe for humans? , 2004, Toxicology letters.
[31] J. Haynes,et al. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.
[32] J. Cumming,et al. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. , 1997, Advances in pharmacology.
[33] H. Keul. Über Konstitution und Entstehung der Ozonide von Bis‐adamantyliden und von Bis‐bicyclo [3.3.1]non‐9‐yliden , 1975 .
[34] S. Meshnick,et al. Artemisinin: mechanisms of action, resistance and toxicity. , 2002, International journal for parasitology.
[35] S. Sine,et al. Lysine Scanning Mutagenesis Delineates Structural Model of the Nicotinic Receptor Ligand Binding Domain* , 2002, The Journal of Biological Chemistry.
[36] J. Changeux,et al. Allosteric receptors after 30 years , 1998, Neuron.
[37] J. Trudell,et al. Coupling of agonist binding to channel gating in the GABAA receptor , 2003, Nature.
[38] P. Taylor,et al. Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells. , 1979, The Journal of biological chemistry.
[39] M. Avery,et al. Stereoselective Total Synthesis of (+)‐Artemisinin, the Antimalarial Constituent of Artemisia annua L. , 1992 .
[40] J. Dilger,et al. The noncompetitive inhibitor quinacrine modifies the desensitization kinetics of muscle acetylcholine receptors. , 2001, Molecular pharmacology.
[41] Y. Fujiyoshi,et al. Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits. , 2002, Journal of molecular biology.
[42] C. W. Jefford. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. , 2001, Current medicinal chemistry.
[43] M B Jackson,et al. Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[44] N. White,et al. Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.